Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Abstract Background Prostein (P501S), also termed solute carrier family 45 member 3 (SLC45A3) is an androgen regulated protein which is preferentially expressed in prostate epithelial cells. Because of its frequent expression in prostate cancer, prostein was suggested a diagnostic prostate cancer ma...
Saved in:
Main Authors: | Florian Viehweger (Author), Carola Böcker (Author), Sören Weidemann (Author), Morton Freytag (Author), Anne Menz (Author), Franziska Büscheck (Author), Andreas M. Luebke (Author), Devita Putri (Author), Martina Kluth (Author), Claudia Hube-Magg (Author), Andrea Hinsch (Author), Maximilian Lennartz (Author), Florian Lutz (Author), Viktor Reiswich (Author), Doris Höflmayer (Author), Christoph Fraune (Author), Katharina Möller (Author), Christian Bernreuther (Author), Patrick Lebok (Author), Guido Sauter (Author), Stefan Steurer (Author), David Dum (Author), Andreas H. Marx (Author), Ronald Simon (Author), Till Krech (Author), Till S. Clauditz (Author), Frank Jacobsen (Author), Natalia Gorbokon (Author), Eike Burandt (Author), Sarah Minner (Author), Simon Kind (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Diagnostic and prognostic impact of cytokeratin 18 expression in human tumors: a tissue microarray study on 11,952 tumors
by: Anne Menz, et al.
Published: (2021) -
E-Cadherin expression in human tumors: a tissue microarray study on 10,851 tumors
by: Eike Burandt, et al.
Published: (2021) -
p63 expression in human tumors and normal tissues: a tissue microarray study on 10,200 tumors
by: Stefan Steurer, et al.
Published: (2021) -
Pattern of placental alkaline phosphatase (PLAP) expression in human tumors: a tissue microarray study on 12,381 tumors
by: Viktor Reiswich, et al.
Published: (2021) -
Upregulation of the transcription factor TFAP2D is associated with aggressive tumor phenotype in prostate cancer lacking the TMPRSS2:ERG fusion
by: Christoph Fraune, et al.
Published: (2020)